Acquisition of Biacore T-100 at URI

在 URI 收购 Biacore T-100

• 批准号: 8052075
• 负责人: Bongsup P Cho
• 金额: $ 35.17万
• 依托单位: UNIVERSITY OF RHODE ISLAND
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-02-15 至 2012-02-14
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8052075
• 关键词: Arts; Biological Sciences; Biosensing Techniques; Communities; Ecology; Engineering; Funding; Minor; Molecular; Molecular Conformation; Mutation; Nanotechnology; Nature; Nuclear Receptors; Pharmacy facility; Phosphotransferases; Research Personnel; Research Project Grants; Rhode Island; Science; Substrate Interaction; Surface Plasmon Resonance; Technology; United States National Institutes of Health; Universities; base; cancer imaging; cancer therapy; college; instrument; repaired; tool

DESCRIPTION (provided by applicant): We wish to acquire a Biacore T-100, a chip-based biosensing instrument employing surface plasmon resonance (SPR) technology. This tool will provide biomedical investigators at the University of Rhode Island (URI) with state-of the-art capability for studying dynamic macromolecular interactions. The biomedical and molecular science community at URI has grown significantly in the past several years and we now have a critical mass of SPR users: six R01 grantees as major users and 15 minor users, many of whom have substantial funding support from NIH and other agencies. These investigators are affiliated with four different colleges: Pharmacy, Arts & Sciences, Environmental & Life Sciences, and Engineering. The proposed research projects are diverse and interdisciplinary in nature, involving nanotechnology for cancer imaging and therapy, kinase-substrate interactions, nuclear receptor interactions, and the effect of replication fork conformation on mutation & repair. Consequently, we are poised to make immediate use of the new instrument.

描述（由申请人提供）：我们希望获得 Biacore T-100，这是一种采用表面等离子共振 (SPR) 技术的基于芯片的生物传感仪器。该工具将为罗德岛大学 (URI) 的生物医学研究人员提供研究动态大分子相互作用的最先进的能力。 URI 的生物医学和分子科学界在过去几年中显着发展，我们现在拥有大量 SPR 用户：6 个 R01 受助者作为主要用户，15 个次要用户，其中许多人得到 NIH 和其他机构的大量资金支持。这些研究人员隶属于四个不同的学院：药学院、艺术与科学学院、环境与生命科学学院以及工程学院。拟议的研究项目本质上是多样化和跨学科的，涉及癌症成像和治疗的纳米技术、激酶-底物相互作用、核受体相互作用以及复制叉构象对突变和修复的影响。因此，我们准备立即使用新工具。